HFEA and HTA joint statement on ovarian and testicular tissue storage
The Human Fertilisation and Embryology Authority (HFEA) and the Human Tissue Authority (HTA) have been working together to reduce the regulatory overlap re...
Search results for
Regulating human embryonic stem cell lines for human application
This is the joint position from the Human Tissue Authority (HTA), Human Fertilisation and Embryology Authority (HFEA) and Medicines and Healthcare products...
Regulation of faecal microbiota transplant
Faecal microbiota transplantation (FMT) is recognised as an emerging treatment for recurrent Clostridium difficile infections in patients where antibiotic...
Position on the procurement of tumour material
Guidance for establishments on meeting HTA licensing requirements for the procurement of tumour samples to be used as a starting material in the manufactur...
Compliance resource for US Imports
Importing tissue establishments must ensure that imports from third countries meet standards of quality and safety equivalent to those in the UK.
Clarification of the scope of the Medical Devices Regulation for tissues and cells products
New EU regulations for medical devices (MDR) and in-vitro medical devices (IVDR) have been introduced.
Consent exemptions under the Human Tissue Act 2004
This section explains the consent exemptions from the Human Tissue Act (2004) (HT Act).
Disposal of anatomical specimens
Disposal of relevant material is one of the statutory activities within the remit of the Human Tissue Authority (HTA).
Accessibility statement
This accessibility statement applies to https://www.hta.gov.uk and a
London Anatomy Office medical school
The London Anatomy Office is not licensed by the HTA, but provides a service for co-ordinating the donation of bodies for the following licensed establishm...